DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,115,308 | +7.1% | 73,016 | +3.6% | 0.45% | +11.1% |
| Q2 2023 | $16,917,631 | +93564.2% | 70,490 | -1.6% | 0.40% | -13.9% |
| Q1 2023 | $18,062 | +2.1% | 71,664 | +7.6% | 0.47% | -3.3% |
| Q4 2022 | $17,685 | -99.9% | 66,630 | +0.2% | 0.48% | -6.4% |
| Q3 2022 | $17,169,000 | +1.7% | 66,473 | -0.2% | 0.52% | +9.1% |
| Q2 2022 | $16,888,000 | -12.2% | 66,614 | +1.5% | 0.48% | +4.4% |
| Q1 2022 | $19,245,000 | -3.3% | 65,608 | +8.5% | 0.46% | +2.0% |
| Q4 2021 | $19,894,000 | +13.6% | 60,467 | +5.1% | 0.45% | +4.0% |
| Q3 2021 | $17,507,000 | +17.0% | 57,507 | +3.1% | 0.43% | +16.9% |
| Q2 2021 | $14,962,000 | +24.3% | 55,753 | +4.3% | 0.37% | +13.6% |
| Q1 2021 | $12,034,000 | +7.1% | 53,464 | +5.7% | 0.32% | +0.9% |
| Q4 2020 | $11,241,000 | +9.1% | 50,601 | +5.7% | 0.32% | -4.5% |
| Q3 2020 | $10,306,000 | +23.8% | 47,862 | +1.7% | 0.34% | +7.7% |
| Q2 2020 | $8,323,000 | +31.5% | 47,067 | +2.9% | 0.31% | +9.5% |
| Q1 2020 | $6,331,000 | -13.7% | 45,739 | -4.3% | 0.28% | +9.7% |
| Q4 2019 | $7,338,000 | +18.5% | 47,808 | +11.5% | 0.26% | +9.3% |
| Q3 2019 | $6,191,000 | +2.5% | 42,863 | +1.4% | 0.24% | -2.5% |
| Q2 2019 | $6,042,000 | +16.6% | 42,274 | +7.7% | 0.24% | +7.5% |
| Q1 2019 | $5,184,000 | +27.8% | 39,265 | -0.2% | 0.23% | +12.4% |
| Q4 2018 | $4,055,000 | -4.9% | 39,327 | +0.2% | 0.20% | +6.9% |
| Q3 2018 | $4,264,000 | -13.8% | 39,243 | -21.7% | 0.19% | -15.3% |
| Q2 2018 | $4,947,000 | +24.5% | 50,129 | +23.5% | 0.22% | +14.4% |
| Q1 2018 | $3,973,000 | +88.5% | 40,577 | +78.7% | 0.19% | +68.7% |
| Q4 2017 | $2,108,000 | +8.8% | 22,706 | +0.5% | 0.12% | +2.7% |
| Q3 2017 | $1,938,000 | -0.8% | 22,597 | -2.4% | 0.11% | -5.1% |
| Q2 2017 | $1,953,000 | +3.4% | 23,142 | +4.8% | 0.12% | 0.0% |
| Q1 2017 | $1,889,000 | +7.8% | 22,084 | -1.9% | 0.12% | 0.0% |
| Q4 2016 | $1,753,000 | -2.6% | 22,515 | -1.9% | 0.12% | -4.8% |
| Q3 2016 | $1,799,000 | -22.6% | 22,943 | -0.2% | 0.12% | -24.4% |
| Q2 2016 | $2,323,000 | +16.4% | 22,996 | +9.3% | 0.16% | +13.9% |
| Q1 2016 | $1,996,000 | +1.8% | 21,045 | -0.3% | 0.14% | -0.7% |
| Q4 2015 | $1,961,000 | +14.8% | 21,115 | +5.3% | 0.14% | +7.4% |
| Q3 2015 | $1,708,000 | +3.5% | 20,045 | +3.1% | 0.14% | +5.5% |
| Q2 2015 | $1,651,000 | 0.0% | 19,445 | 0.0% | 0.13% | 0.0% |
| Q1 2015 | $1,651,000 | +132.9% | 19,445 | +135.0% | 0.13% | +103.2% |
| Q4 2014 | $709,000 | +9.8% | 8,275 | -2.6% | 0.06% | +5.0% |
| Q3 2014 | $646,000 | – | 8,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |